thanks john hopkins for hoestin this, and pew for providing space. transparency can be a powerful tool for innovation. new platforms for visualizing large complex data sets present important new opportunities for the research and development community for regulators and for clinicians. it allows people to harness data to advance the safe and effective and efficient development for medical needs and to communicate information supporting regulatory decision making in ways that engender greater public confidence in those decisions. the fda's goal is to advance transparency without reducing incentives to innovate. this can be accomplished by meeting our statutory responsibility for protecting confidential, commercial information, trade secrets and private data while disseminating more information gnat supports and informs more regulatory decisions and patient care when ones products are approved for use. with these safe guards in place, transparency is a tide that can lend to all boats. to identify areas requiring additional post-market research and to g